<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3046">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04373148</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-55689</org_study_id>
    <secondary_id>2U19AI057229</secondary_id>
    <secondary_id>20-006-ACTT</secondary_id>
    <nct_id>NCT04373148</nct_id>
  </id_info>
  <brief_title>Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19</brief_title>
  <official_title>Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified
      coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults
      and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to
      participate in this study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 8, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Testing Immunity to SARS-CoV-2 over time</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Testing the virus over time</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Coronavirus</condition>
  <arm_group>
    <arm_group_label>COVID-19</arm_group_label>
    <description>Adults diagnosed with COVID-19</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Adults not diagnosed with COVID-19</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>There is no intervention</intervention_name>
    <description>There is no intervention</description>
    <arm_group_label>COVID-19</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample and optional nasopharyngeal swab, cheek swab with saliva collection, nasal swab,
      stool sample, blood microsample, and endotracheal aspirate (sputum samples)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adults (18 years and older) and children diagnosed and not diagnosed (controls) with
        COVID-19
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (18 years and older) and children with confirmed COVID-19 (RT-PCR diagnosis).

          -  Adults (18 years and older) and children without COVID-19 for controls (who test
             negative for COVID-19 but may have viral symptoms)

        Exclusion Criteria:

          -  Patients with special risks attendant to venipuncture will be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kari Nadeau, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hena Din</last_name>
    <phone>(650) 521-7237</phone>
    <email>henadin@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University, Hospital, and Clinics</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94035</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hena Din</last_name>
      <phone>650-521-7237</phone>
      <email>henadin@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>April 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2020</study_first_posted>
  <last_update_submitted>August 31, 2020</last_update_submitted>
  <last_update_submitted_qc>August 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Kari Christine Nadeau, MD PhD</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Immunity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

